Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.52 |
| ▸ | SENP2 | Q9HC62 | 3/20 | 0.49 |
| ▸ | SUMO2 | P61956 | 2/20 | 0.49 |
| ▸ | SUMO1 | P63165 | 2/20 | 0.49 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.49 |
| ▸ | SENP1 | Q9P0U3 | 2/20 | 0.49 |
| ▸ | SENP3 | Q9H4L4 | 1/20 | 0.49 |
| ▸ | ENPP2 | Q13822 | 9/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15424233 | 0.90 | PHLPP2 (0.58) | PHLPP2CYP1A2GLO1SENP2SUMO2 | |
| SCHEMBL12260113 | 0.87 | PHLPP2 (0.65) | PHLPP2CYP1A2GLO1SENP2SUMO2 | |
| SCHEMBL12906884 | 0.86 | ENPP2 (0.52) | PHLPP2CYP1A2GLO1ENPP2CYP2C9 | |
| SCHEMBL15268155 | 0.86 | PHLPP2 (0.70) | PHLPP2CYP1A2GLO1SENP2SUMO2 | |
| SCHEMBL13631320 | 0.86 | PHLPP2 (0.56) | PHLPP2CYP1A2GLO1SENP2SUMO2 | |
| SCHEMBL15281267 | 0.85 | SENP2 (0.63) | PHLPP2CYP1A2GLO1SENP2SUMO2 | |
| SCHEMBL13949161 | 0.83 | ENPP2 (0.63) | PHLPP2CYP1A2SENP2SUMO2SUMO1 | |
| SCHEMBL16488626 | 0.82 | PHLPP2 (0.66) | PHLPP2CYP1A2GLO1SENP2SUMO2 | |
| SCHEMBL15268146 | 0.82 | PHLPP2 (0.50) | PHLPP2CYP1A2GLO1SENP2SUMO2 | |
| SCHEMBL13980954 | 0.81 | CYP1A2 (0.56) | PHLPP2CYP1A2SENP2SUMO2SUMO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7619074-B2 | Reactive dyestuff with N,N-dialkylamino bridge group | EVERLIGHT USA, INC. (US) | 2009-11-17 | — | — | US | disclosed |
| US-20090176972-A1 | Novel reactive dyestuff with N,N-dialkylamino bridge group | EVERLIGHT USA, INC. (US) | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176972-A1 | Novel reactive dyestuff with N,N-dialkylamino bridge group | SRM, PADI1, NOS1 | PHLPP2 4316/4885CYP1A2 89/4885GLO1 766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.